Case Reports

Nivolumab and dinutuximab beta in two patients with refractory neuroblastoma
Karoline Ehlert, Ina Hansjuergens, Andreas Zinke, Sylke Otto, Nikolai Siebert, Guenter Henze, Holger Lode

Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000540; DOI: 10.1136/jitc-2020-000540
Diffuse pneumonitis from coronavirus HKU1 on checkpoint inhibitor therapy
Michael T Serzan, Princy N Kumar, Michael B Atkins

Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000898; DOI: 10.1136/jitc-2020-000898
Personalized neoantigen-based immunotherapy for advanced collecting duct carcinoma: case report
Yongyi Zeng, Wei Zhang, Zhenli Li, Youshi Zheng, Yingchao Wang, Geng Chen, Liman Qiu, Kun Ke, Xiaoping Su, Zhixiong Cai, Jingfeng Liu, Xiaolong Liu

Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000217; DOI: 10.1136/jitc-2019-000217
Combination checkpoint blockade for metastatic cutaneous malignancies in kidney transplant recipients
Megan H Trager, Shana M Coley, Geoffrey Dube, Shaheer Khan, Matthew Ingham, Faramarz H Samie, Larisa J Geskin, Diana McDonnell, Daniel Brouder, Yvonne Saenger, Richard Carvajal

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000908; DOI: 10.1136/jitc-2020-000908
Nivolumab-induced synovitis is characterized by florid T cell infiltration and rapid resolution with synovial biopsy-guided therapy
William Murray-Brown, Tom D Wilsdon, Helen Weedon, Susanna Proudman, Shawgi Sukumaran, Sonja Klebe, Jennifer G Walker, Malcolm D Smith, Mihir D Wechalekar

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000281; DOI: 10.1136/jitc-2019-000281
Hyperprogression to camrelizumab in a patient with esophageal squamous cell carcinoma harboring EGFR kinase domain duplication
Wei Wang, Meihong Wu, Minglu Liu, Zhengqing Yan, Guoqiang Wang, Dongliang Mao, Mei Wang

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000793; DOI: 10.1136/jitc-2020-000793
Small cell transformation of non-small cell lung cancer on immune checkpoint inhibitors: uncommon or under-recognized?
Kartik Sehgal, Andreas Varkaris, Hollis Viray, Paul A VanderLaan, Deepa Rangachari, Daniel B Costa

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000697; DOI: 10.1136/jitc-2020-000697
Calcium-sensing receptor autoantibody-mediated hypoparathyroidism associated with immune checkpoint inhibitor therapy: diagnosis and long-term follow-up
Ramona Dadu, Theresa E Rodgers, Van A Trinh, Elizabeth Helen Kemp, Trisha D Cubb, Sapna Patel, Julie M Simon, Elizabeth M Burton, Hussein Tawbi

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000687; DOI: 10.1136/jitc-2020-000687
Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration
Natalia Maximova, Alessandra Maestro, Davide Zanon, Annalisa Marcuzzi

Journal for ImmunoTherapy of Cancer Feb 2020, 8 (1) e000388; DOI: 10.1136/jitc-2019-000388
T-cell lymphoma secondary to checkpoint inhibitor therapy
Kartik Anand, Joe Ensor, Sai Ravi Pingali, Patrick Hwu, Madeleine Duvic, Stephen Chiang, Roberto Miranda, Youli Zu, Swaminathan Iyer

Journal for ImmunoTherapy of Cancer Feb 2020, 8 (1) e000104; DOI: 10.1136/jitc-2019-000104

Main menu

Case Reports

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Case Reports

Pages